Article
Cancer-associated SF3B1 mutants recognize otherwise inaccessible cryptic 3' splice sites within RNA secondary structures.
Oncogene - 23 Feb 2017
Kesarwani A K, Ramirez O, Gupta A K, Yang X, Murthy T, Minella A C, Pillai M M
Abstract excerpt
Recurrent mutations in core splicing factors have been reported in several clonal disorders, including cancers. Mutations in SF3B1, a component of the U2 splicing complex, are the most common. SF3B1 mutations are associated with aberrant pre-mRNA splicing using cryptic 3' splice sites (3'SSs), but the mechanism of their selection is not clear. To understand how cryptic 3'SSs are selected, we performed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
